More patients aged 75 and over should be prescribed drugs to help lower their risk of cardiovascular disease, a study published today in the British Medical Journal suggests.
Jul 12, 2012
0
0
Cholesterol-lowering statin drugs appear to be associated with reduced risk of recurrent cardiovascular events in men and women, but do not appear to be associated with reduced all-cause mortality or stroke in women, according ...
Jun 25, 2012
0
0
(Medical Xpress) -- A simple diagnostic test developed at Oxford University, and launched today by Massachusetts-based Boston Heart Diagnostics, will identify those at increased risk of rare but serious side effects from ...
Jun 1, 2012
1
0
(AP) -- The clock is ticking: The first National Alzheimer's Plan sets a deadline of 2025 to finally find effective ways to treat, or at least stall, the mind-destroying disease.
May 15, 2012
0
0
A cholesterol drug commonly prescribed to reduce cardiovascular disease risk restores blood vessel function in a mouse model of Alzheimer's disease, according to a study in the April 4 issue of The Journal of Neuroscience. ...
Apr 3, 2012
0
0
Regular use of cholesterol-lowering statin drugs may be associated with a modest reduction in risk for developing Parkinson disease, particularly among younger patients, according to a study in the March issue of Archives ...
Mar 12, 2012
0
0
(AP) -- Federal regulators have rejected Merck & Co.'s new combination cholesterol drug, which includes a generic version of the mega-blockbuster Lipitor - at least for now.
Mar 5, 2012
0
0
(AP) -- Federal health officials are adding new safety warnings about risks of memory loss and elevated blood sugar to statins, a widely prescribed group of cholesterol-lowering medications.
Feb 28, 2012
0
0
In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance is approximately 400 percent higher than comparable costs paid by the government in the ...
Jan 5, 2012
12
0
Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show.
Dec 20, 2011
3
0
